DPT vaccine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "DPT vaccine" in English language version.

refsWebsite

Global rank English rank

62web.archive.org

1^st place

38nih.gov

4^th place

24cdc.gov

218^th place

212^th place

13doi.org

2^nd place

11fda.gov

447^th place

338^th place

8archive-it.org

910^th place

593^rd place

5immunize.org

low place

4nhs.uk

1,989^th place

1,528^th place

2uptodate.com

3,771^st place

2,605^th place

2health.gov.au

low place

8,252^nd place

2tga.gov.au

3,984^th place

2,622^nd place

1ourworldindata.org

2,263^rd place

1,687^th place

1europa.eu

68^th place

117^th place

1hhs.gov

5,973^rd place

3,693^rd place

1pfizer.com

low place

1npr.org

92^nd place

72^nd place

1unicef.org

1,791^st place

1,568^th place

1health.gov

low place

1who.int

195^th place

302^nd place

1phac-aspc.gc.ca

low place

1semanticscholar.org

11^th place

8^th place

1worldcat.org

5^th place

1healthlinkbc.ca

low place

1gov.uk

432^nd place

278^th place

1rijksvaccinatieprogramma.nl

low place

1icsi.org

low place

1stagnessurgery.com.au

low place

archive-it.org

wayback.archive-it.org

"Daptacel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Infanrix". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Kinrix". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Pediarix". U.S. Food and Drug Administration (FDA). 23 July 2017. Archived from the original on 23 July 2017. Retrieved 17 July 2020.
"Pentacel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Quadracel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Adacel". U.S. Food and Drug Administration (FDA). Archived from the original on 23 July 2017.
"Boostrix". U.S. Food and Drug Administration (FDA). Archived from the original on 22 July 2017.

cdc.gov

"DTaP (Diphtheria, Tetanus, Pertussis) Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 1 April 2020. Archived from the original on 28 December 2019. Retrieved 27 July 2020. This article incorporates text from this source, which is in the public domain.
"Birth-18 Years Immunization Schedule". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 6 March 2016. Retrieved 30 July 2020.
"Diphtheria, Tetanus, and Whooping Cough Vaccination". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 11 August 2020. Retrieved 4 August 2020.
"FastStats". U.S. Centers for Disease Control and Prevention (CDC). 6 September 2022. Archived from the original on 12 May 2022. Retrieved 12 September 2022.
"Safety Information for Diphtheria, Tetanus, and Pertussis Vaccines". U.S. Centers for Disease Control and Prevention (CDC). 15 June 2020. Archived from the original on 5 August 2020. Retrieved 28 July 2020. This article incorporates text from this source, which is in the public domain.
Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. (December 2006). "Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel" (PDF). MMWR. Recommendations and Reports. 55 (RR-17): 1–37. PMID 17167397. Archived (PDF) from the original on 19 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (January 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (1): 13–15. PMID 21228763. Archived (PDF) from the original on 20 March 2021. Retrieved 26 September 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (February 2013). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012" (PDF). MMWR. Morbidity and Mortality Weekly Report. 62 (7): 131–135. PMC 4604886. PMID 23425962. Archived (PDF) from the original on 17 October 2020. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. (March 2006). "Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 55 (RR-3): 1–34. PMID 16557217. Archived (PDF) from the original on 21 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
"ACIP Votes to Recommend Use of Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccine for Adults" (PDF). U.S. Centers for Disease Control and Prevention (CDC). Archived from the original (PDF) on 19 October 2006. This article incorporates text from this source, which is in the public domain.
"General Recommendations on Immunization". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 5 August 2020. Retrieved 4 August 2020.
"Td (Tetanus, Diphtheria) Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 1 March 2020. Archived from the original on 28 December 2019. Retrieved 27 July 2020.
"Diphtheria Vaccination". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 14 April 2020. Retrieved 18 April 2020.
Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. (2008). Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) (PDF) (10th ed. (2nd printing) ed.). Washington, D.C.: Public Health Foundation. Archived from the original (PDF) on 24 September 2008. Retrieved 29 November 2008.
Hamborsky J, Kroger A, Wolfe S, eds. (2015). "Chapter 21: Tetanus". Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: U.S. Centers for Disease Control and Prevention (CDC). ISBN 978-0990449119. Archived from the original on 30 December 2016. Retrieved 28 January 2020.
Hamborsky J, Kroger A, Wolfe S, eds. (2015). "Chapter 16: Pertussis". Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: U.S. Centers for Disease Control and Prevention (CDC). ISBN 978-0990449119. Archived from the original on 30 December 2016. Retrieved 28 January 2020.
"Diphtheria-Tetanus-Pertussis Vaccine Information Statement | CDC". U.S. Centers for Disease Control and Prevention (CDC). 27 June 2022. Archived from the original on 28 December 2019. Retrieved 12 September 2022.
"Summary of Pertussis Vaccination Recommendations | CDC". U.S. Centers for Disease Control and Prevention (CDC). 6 May 2022. Archived from the original on 12 September 2022. Retrieved 12 September 2022.
"Pertussis | Pregnancy and Whooping Cough | Your Baby Needs Vaccines on Time | CDC". U.S. Centers for Disease Control and Prevention (CDC). 14 February 2019. Archived from the original on 15 July 2020. Retrieved 30 July 2020.
"Tetanus, diphtheria, and pertussis vaccination". U.S. Centers for Disease Control and Prevention (CDC). 3 February 2020. Archived from the original on 21 July 2020. Retrieved 29 July 2020.
"Tdap (Pertussis) Vaccine and Pregnancy". U.S. Centers for Disease Control and Prevention (CDC). 10 April 2019. Archived from the original on 28 July 2020. Retrieved 28 July 2020.
Centers for Disease Control Prevention (CDC) (October 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (41): 1424–1426. PMID 22012116. Archived (PDF) from the original on 14 April 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
"Tdap (Pertussis) Vaccine and Pregnancy | CDC". U.S. Centers for Disease Control and Prevention (CDC). 15 January 2021. Archived from the original on 28 July 2020. Retrieved 12 September 2022.
"About Diphtheria, Tetanus, and Pertussis Vaccination". Centers for Disease Control and Prevention (CDC). 22 January 2020. Archived from the original on 7 January 2021. Retrieved 16 July 2020.

doi.org

Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. (April 2018). "Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports. 67 (2): 1–44. doi:10.15585/mmwr.rr6702a1. PMC 5919600. PMID 29702631. This article incorporates text from this source, which is in the public domain.
Kuchar E, Karlikowska-Skwarnik M, Han S, Nitsch-Osuch A (2016). "Pertussis: History of the Disease and Current Prevention Failure". Pulmonary Dysfunction and Disease. Advances in Experimental Medicine and Biology. Vol. 934. pp. 77–82. doi:10.1007/5584_2016_21. ISBN 978-3-319-42009-7. PMID 27256351.
Hebert CJ, Hall CM, Odoms LN (May 2012). "Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century". Human Vaccines & Immunotherapeutics. 8 (5): 560–568. doi:10.4161/hv.19204. PMC 3495718. PMID 22617834.
Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. (2019). "Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines". Frontiers in Immunology. 10: 1344. doi:10.3389/fimmu.2019.01344. PMC 6616129. PMID 31333640.
de Araújo Veras AA, Arruda Vidal S, Costa de Macêdo V, de Carvalho Lima M, Cabral de Lira PI, da Fonseca Lima EJ, et al. (2021). "Prevalence, Trends and Conditions for the DTP3 Vaccine: A 25-Year Historical Perspective". Risk Management and Healthcare Policy. 14: 4301–4310. doi:10.2147/RMHP.S312263. PMC 8524252. PMID 34703341.
DeDea L (January 2011). "The difference between Tdap and DTaP; dabigatran versus warfarin". JAAPA. 24 (1): 14. doi:10.1097/01720610-201101000-00002. PMID 21261140.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.
Bar-On ES, Goldberg E, Hellmann S, Leibovici L (April 2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". The Cochrane Database of Systematic Reviews. 4 (4): CD005530. doi:10.1002/14651858.CD005530.pub3. PMID 22513932. S2CID 205179339.
Carpenter CS, Lawler EC (2019). "Direct and Spillover Effects of Middle School Vaccination Requirements". American Economic Journal: Economic Policy. 11 (1): 95–125. doi:10.1257/pol.20170067. ISSN 1945-7731.
Vygen-Bonnet S, Hellenbrand W, Garbe E, von Kries R, Bogdan C, Heininger U, et al. (February 2020). "Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review". BMC Infectious Diseases. 20 (1): 136. doi:10.1186/s12879-020-4824-3. PMC 7020352. PMID 32054444.
Furuta M, Sin J, Ng ES, Wang K (November 2017). "Efficacy and safety of pertussis vaccination for pregnant women — a systematic review of randomised controlled trials and observational studies". BMC Pregnancy and Childbirth. 17 (1): 390. doi:10.1186/s12884-017-1559-2. PMC 5700667. PMID 29166874.
Pool V, Tomovici A, Johnson DR, Greenberg DP, Decker MD (April 2018). "Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA". Vaccine. 36 (17): 2282–2287. doi:10.1016/j.vaccine.2018.03.029. PMID 29573876.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.

europa.eu

ema.europa.eu

"List of nationally authorised medicinal products" (PDF). ema.europa.eu. Retrieved 4 July 2024.

fda.gov

"Pediarix". U.S. Food and Drug Administration (FDA). 6 November 2019. Archived from the original on 22 September 2019. Retrieved 30 April 2022.
"FDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Age". U.S. Food and Drug Administration (FDA) (Press release). 7 October 2022. Archived from the original on 7 October 2022. Retrieved 7 October 2022. This article incorporates text from this source, which is in the public domain.
"Licensed Biological Products with Supporting Documents". U.S. Food and Drug Administration (FDA). 7 July 2020. Archived from the original on 21 September 2020. Retrieved 17 July 2020.
"Daptacel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Infanrix". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Kinrix". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Pediarix". U.S. Food and Drug Administration (FDA). 23 July 2017. Archived from the original on 23 July 2017. Retrieved 17 July 2020.
"Pentacel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Quadracel". U.S. Food and Drug Administration (FDA). 22 July 2017. Archived from the original on 22 July 2017. Retrieved 17 July 2020.
"Adacel". U.S. Food and Drug Administration (FDA). Archived from the original on 23 July 2017.
"Boostrix". U.S. Food and Drug Administration (FDA). Archived from the original on 22 July 2017.

gov.uk

"Hexavalent 6-in-1 vaccine to be made available to newborn babies". GOV.UK. Archived from the original on 30 April 2022. Retrieved 30 April 2022.

health.gov

"Increase the coverage level of 4 doses of the DTaP vaccine in children by age 2 years — IID‑06 - Healthy People 2030 | health.gov". health.gov. Archived from the original on 12 September 2022. Retrieved 12 September 2022.

health.gov.au

immunisationhandbook.health.gov.au

"Adacel". The Australian Immunisation Handbook. 4 June 2018. Archived from the original on 18 June 2020. Retrieved 18 July 2020.
"Adacel Polio". The Australian Immunisation Handbook. 5 June 2018. Archived from the original on 18 June 2020. Retrieved 18 July 2020.

healthlinkbc.ca

"Tetanus and Diphtheria (Td) Vaccine". HealthLink BC. 13 June 2016. Archived from the original on 19 September 2020. Retrieved 18 April 2020.

hhs.gov

"Vaccine Types". HHS. 26 April 2021. Archived from the original on 16 July 2021. Retrieved 19 September 2022.

icsi.org

Health Care Guideline: Routine Prenatal Care. Fourteenth Edition. Archived 24 June 2012 at the Wayback Machine By the Institute for Clinical Systems Improvement. July 2010.

immunize.org

"standing orders for Administering Diphtheria, Tetanus, and Acellular Pertussis (DTaP)Vaccine to Children YoungerThan Age 7Years" (PDF). immunize.org. Archived (PDF) from the original on 26 February 2024. Retrieved 4 July 2024.
"standing orders for Administering Tdap/Td Vaccine to Children and Teens Age 7 Years and Older" (PDF). immunize.org. Archived (PDF) from the original on 10 June 2024. Retrieved 4 July 2024.
"standing orders for Administering Td/Tdap Vaccine to Adults" (PDF). immunize.org. Archived (PDF) from the original on 26 February 2024. Retrieved 4 July 2024.
"standing orders for Administering Tdap During Pregnancy" (PDF). immunize.org. Archived (PDF) from the original on 19 May 2024. Retrieved 4 July 2024.
"Vaccine Timeline: Historic Dates and Events Related to Vaccines and Immunization". Immunization Action Coalition. 17 May 2013. Archived from the original on 6 April 2020. Retrieved 25 June 2014.

nhs.uk

"3-in-1 teenage booster overview". nhs.uk. 31 July 2019. Archived from the original on 19 April 2021. Retrieved 22 September 2020.
"Tetanus". 18 October 2017. Archived from the original on 23 July 2021. Retrieved 22 September 2020.
"Travel vaccinations". 23 October 2017. Archived from the original on 11 August 2021. Retrieved 22 September 2020.
NHS https://www.nhs.uk/conditions/vaccinations/3-in-1-teenage-booster/ Archived 19 April 2021 at the Wayback Machine

nih.gov

pubmed.ncbi.nlm.nih.gov

Syed MA (February 2017). "Choosing from Whole Cell and Acellular Pertussis Vaccines-Dilemma for the Developing Countries". Iranian Journal of Public Health. 46 (2): 272–273. PMC 5402791. PMID 28451568.
Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. (April 2018). "Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports. 67 (2): 1–44. doi:10.15585/mmwr.rr6702a1. PMC 5919600. PMID 29702631. This article incorporates text from this source, which is in the public domain.
Kuchar E, Karlikowska-Skwarnik M, Han S, Nitsch-Osuch A (2016). "Pertussis: History of the Disease and Current Prevention Failure". Pulmonary Dysfunction and Disease. Advances in Experimental Medicine and Biology. Vol. 934. pp. 77–82. doi:10.1007/5584_2016_21. ISBN 978-3-319-42009-7. PMID 27256351.
Hebert CJ, Hall CM, Odoms LN (May 2012). "Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century". Human Vaccines & Immunotherapeutics. 8 (5): 560–568. doi:10.4161/hv.19204. PMC 3495718. PMID 22617834.
Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. (2019). "Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines". Frontiers in Immunology. 10: 1344. doi:10.3389/fimmu.2019.01344. PMC 6616129. PMID 31333640.
de Araújo Veras AA, Arruda Vidal S, Costa de Macêdo V, de Carvalho Lima M, Cabral de Lira PI, da Fonseca Lima EJ, et al. (2021). "Prevalence, Trends and Conditions for the DTP3 Vaccine: A 25-Year Historical Perspective". Risk Management and Healthcare Policy. 14: 4301–4310. doi:10.2147/RMHP.S312263. PMC 8524252. PMID 34703341.
DeDea L (January 2011). "The difference between Tdap and DTaP; dabigatran versus warfarin". JAAPA. 24 (1): 14. doi:10.1097/01720610-201101000-00002. PMID 21261140.
Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. (December 2006). "Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel" (PDF). MMWR. Recommendations and Reports. 55 (RR-17): 1–37. PMID 17167397. Archived (PDF) from the original on 19 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (January 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (1): 13–15. PMID 21228763. Archived (PDF) from the original on 20 March 2021. Retrieved 26 September 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (February 2013). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012" (PDF). MMWR. Morbidity and Mortality Weekly Report. 62 (7): 131–135. PMC 4604886. PMID 23425962. Archived (PDF) from the original on 17 October 2020. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.
Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. (March 2006). "Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 55 (RR-3): 1–34. PMID 16557217. Archived (PDF) from the original on 21 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Bar-On ES, Goldberg E, Hellmann S, Leibovici L (April 2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". The Cochrane Database of Systematic Reviews. 4 (4): CD005530. doi:10.1002/14651858.CD005530.pub3. PMID 22513932. S2CID 205179339.
Vygen-Bonnet S, Hellenbrand W, Garbe E, von Kries R, Bogdan C, Heininger U, et al. (February 2020). "Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review". BMC Infectious Diseases. 20 (1): 136. doi:10.1186/s12879-020-4824-3. PMC 7020352. PMID 32054444.
Furuta M, Sin J, Ng ES, Wang K (November 2017). "Efficacy and safety of pertussis vaccination for pregnant women — a systematic review of randomised controlled trials and observational studies". BMC Pregnancy and Childbirth. 17 (1): 390. doi:10.1186/s12884-017-1559-2. PMC 5700667. PMID 29166874.
Gilley M, Goldman RD (February 2014). "Protecting infants from pertussis". Canadian Family Physician. 60 (2): 138–140. PMC 3922557. PMID 24522676.
Pool V, Tomovici A, Johnson DR, Greenberg DP, Decker MD (April 2018). "Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA". Vaccine. 36 (17): 2282–2287. doi:10.1016/j.vaccine.2018.03.029. PMID 29573876.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (October 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (41): 1424–1426. PMID 22012116. Archived (PDF) from the original on 14 April 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.

ncbi.nlm.nih.gov

Syed MA (February 2017). "Choosing from Whole Cell and Acellular Pertussis Vaccines-Dilemma for the Developing Countries". Iranian Journal of Public Health. 46 (2): 272–273. PMC 5402791. PMID 28451568.
Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. (April 2018). "Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports. 67 (2): 1–44. doi:10.15585/mmwr.rr6702a1. PMC 5919600. PMID 29702631. This article incorporates text from this source, which is in the public domain.
Hebert CJ, Hall CM, Odoms LN (May 2012). "Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century". Human Vaccines & Immunotherapeutics. 8 (5): 560–568. doi:10.4161/hv.19204. PMC 3495718. PMID 22617834.
Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. (2019). "Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines". Frontiers in Immunology. 10: 1344. doi:10.3389/fimmu.2019.01344. PMC 6616129. PMID 31333640.
de Araújo Veras AA, Arruda Vidal S, Costa de Macêdo V, de Carvalho Lima M, Cabral de Lira PI, da Fonseca Lima EJ, et al. (2021). "Prevalence, Trends and Conditions for the DTP3 Vaccine: A 25-Year Historical Perspective". Risk Management and Healthcare Policy. 14: 4301–4310. doi:10.2147/RMHP.S312263. PMC 8524252. PMID 34703341.
Centers for Disease Control Prevention (CDC) (February 2013). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012" (PDF). MMWR. Morbidity and Mortality Weekly Report. 62 (7): 131–135. PMC 4604886. PMID 23425962. Archived (PDF) from the original on 17 October 2020. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.
Vygen-Bonnet S, Hellenbrand W, Garbe E, von Kries R, Bogdan C, Heininger U, et al. (February 2020). "Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review". BMC Infectious Diseases. 20 (1): 136. doi:10.1186/s12879-020-4824-3. PMC 7020352. PMID 32054444.
Furuta M, Sin J, Ng ES, Wang K (November 2017). "Efficacy and safety of pertussis vaccination for pregnant women — a systematic review of randomised controlled trials and observational studies". BMC Pregnancy and Childbirth. 17 (1): 390. doi:10.1186/s12884-017-1559-2. PMC 5700667. PMID 29166874.
Gilley M, Goldman RD (February 2014). "Protecting infants from pertussis". Canadian Family Physician. 60 (2): 138–140. PMC 3922557. PMID 24522676.
Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H (January 2020). "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019". MMWR. Morbidity and Mortality Weekly Report. 69 (3): 77–83. doi:10.15585/mmwr.mm6903a5. PMC 7367039. PMID 31971933. This article incorporates text from this source, which is in the public domain.

dailymed.nlm.nih.gov

"Daptacel (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen- formaldehyde inactivated, bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen injection, suspension)". DailyMed. Sanofi Pasteur Inc. 14 May 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Infanrix- diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 19 July 2020. Retrieved 17 July 2020.
"Kinrix- diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine injection, suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 19 July 2020. Retrieved 17 July 2020.
"Pediarix (diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b- recombinant and inactivated poliovirus vaccine combined injection, suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus b conjugate- tetanus toxoid conjugate vaccine kit)". DailyMed. Sanofi Pasteur Inc. 5 June 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Quadracel- diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine injection, suspension". DailyMed. Sanofi Pasteur Inc. 20 April 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Adacel Tdap (clostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen- formaldehyde inactivated, bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen injection, suspension)". DailyMed. 26 March 2020. Archived from the original on 18 July 2020. Retrieved 29 July 2020.
"Boostrix- tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed suspension". DailyMed. 25 April 2019. Archived from the original on 20 July 2020. Retrieved 29 July 2020.

npr.org

"Is Vaccine Refusal Worth The Risk?". NPR. 26 May 2009. Archived from the original on 6 April 2020. Retrieved 19 June 2009.

ourworldindata.org

"Global vaccination coverage: Diphtheria-tetanus-pertussis (DTP3) immunization". Our World in Data. Archived from the original on 21 April 2020. Retrieved 5 March 2020.

pfizer.com

"Understanding Six Types of Vaccine Technologies". Pfizer. Archived from the original on 20 September 2022. Retrieved 19 September 2022.

phac-aspc.gc.ca

"Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis". PHAC-ASPC.GC.ca. 14 October 2005. Archived from the original on 27 September 2006. Retrieved 3 June 2007.

rijksvaccinatieprogramma.nl

"Dutch National Immunization Program". National Institute for Public Health and the Environment. Archived from the original on 13 May 2020. Retrieved 18 April 2020.

semanticscholar.org

api.semanticscholar.org

Bar-On ES, Goldberg E, Hellmann S, Leibovici L (April 2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". The Cochrane Database of Systematic Reviews. 4 (4): CD005530. doi:10.1002/14651858.CD005530.pub3. PMID 22513932. S2CID 205179339.

stagnessurgery.com.au

"Triple Antigen IPV". St. Agnes Surgery. Archived from the original on 2 May 2021. Retrieved 2 May 2021.

tga.gov.au

ebs.tga.gov.au

"Adacel (Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed))". Therapeutic Goods Administration (TGA). 18 July 2020. Archived from the original on 13 March 2020. Retrieved 18 July 2020.
"Adacel Polio (Pertussis Vaccine — Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated Poliovirus Type 1, 2 and 3 (Vero cell))". Therapeutic Goods Administration (TGA). 18 July 2020. Archived from the original on 13 March 2020. Retrieved 18 July 2020.

unicef.org

UNICEF Supply Division (June 2023). "Diphtheria Tetanus and Pertussis Containing Vaccines: Market and Supply Update" (PDF). Archived (PDF) from the original on 21 October 2023. Retrieved 10 October 2023.

uptodate.com

"UpToDate". uptodate.com. Archived from the original on 15 September 2022. Retrieved 15 September 2022.
"UpToDate". uptodate.com. Archived from the original on 28 August 2021. Retrieved 3 August 2020.

web.archive.org

"Global vaccination coverage: Diphtheria-tetanus-pertussis (DTP3) immunization". Our World in Data. Archived from the original on 21 April 2020. Retrieved 5 March 2020.
"standing orders for Administering Diphtheria, Tetanus, and Acellular Pertussis (DTaP)Vaccine to Children YoungerThan Age 7Years" (PDF). immunize.org. Archived (PDF) from the original on 26 February 2024. Retrieved 4 July 2024.
"standing orders for Administering Tdap/Td Vaccine to Children and Teens Age 7 Years and Older" (PDF). immunize.org. Archived (PDF) from the original on 10 June 2024. Retrieved 4 July 2024.
"standing orders for Administering Td/Tdap Vaccine to Adults" (PDF). immunize.org. Archived (PDF) from the original on 26 February 2024. Retrieved 4 July 2024.
"standing orders for Administering Tdap During Pregnancy" (PDF). immunize.org. Archived (PDF) from the original on 19 May 2024. Retrieved 4 July 2024.
"DTaP (Diphtheria, Tetanus, Pertussis) Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 1 April 2020. Archived from the original on 28 December 2019. Retrieved 27 July 2020. This article incorporates text from this source, which is in the public domain.
"Vaccine Types". HHS. 26 April 2021. Archived from the original on 16 July 2021. Retrieved 19 September 2022.
"Understanding Six Types of Vaccine Technologies". Pfizer. Archived from the original on 20 September 2022. Retrieved 19 September 2022.
"Birth-18 Years Immunization Schedule". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 6 March 2016. Retrieved 30 July 2020.
"Vaccine Timeline: Historic Dates and Events Related to Vaccines and Immunization". Immunization Action Coalition. 17 May 2013. Archived from the original on 6 April 2020. Retrieved 25 June 2014.
"Is Vaccine Refusal Worth The Risk?". NPR. 26 May 2009. Archived from the original on 6 April 2020. Retrieved 19 June 2009.
"Diphtheria, Tetanus, and Whooping Cough Vaccination". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 11 August 2020. Retrieved 4 August 2020.
UNICEF Supply Division (June 2023). "Diphtheria Tetanus and Pertussis Containing Vaccines: Market and Supply Update" (PDF). Archived (PDF) from the original on 21 October 2023. Retrieved 10 October 2023.
"FastStats". U.S. Centers for Disease Control and Prevention (CDC). 6 September 2022. Archived from the original on 12 May 2022. Retrieved 12 September 2022.
"Increase the coverage level of 4 doses of the DTaP vaccine in children by age 2 years — IID‑06 - Healthy People 2030 | health.gov". health.gov. Archived from the original on 12 September 2022. Retrieved 12 September 2022.
"Safety Information for Diphtheria, Tetanus, and Pertussis Vaccines". U.S. Centers for Disease Control and Prevention (CDC). 15 June 2020. Archived from the original on 5 August 2020. Retrieved 28 July 2020. This article incorporates text from this source, which is in the public domain.
Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. (December 2006). "Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel" (PDF). MMWR. Recommendations and Reports. 55 (RR-17): 1–37. PMID 17167397. Archived (PDF) from the original on 19 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (January 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (1): 13–15. PMID 21228763. Archived (PDF) from the original on 20 March 2021. Retrieved 26 September 2020. This article incorporates text from this source, which is in the public domain.
Centers for Disease Control Prevention (CDC) (February 2013). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012" (PDF). MMWR. Morbidity and Mortality Weekly Report. 62 (7): 131–135. PMC 4604886. PMID 23425962. Archived (PDF) from the original on 17 October 2020. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. (March 2006). "Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 55 (RR-3): 1–34. PMID 16557217. Archived (PDF) from the original on 21 March 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
"ACIP Votes to Recommend Use of Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccine for Adults" (PDF). U.S. Centers for Disease Control and Prevention (CDC). Archived from the original (PDF) on 19 October 2006. This article incorporates text from this source, which is in the public domain.
"Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis". PHAC-ASPC.GC.ca. 14 October 2005. Archived from the original on 27 September 2006. Retrieved 3 June 2007.
"General Recommendations on Immunization". U.S. Centers for Disease Control and Prevention (CDC). 2020. Archived from the original on 5 August 2020. Retrieved 4 August 2020.
"Td (Tetanus, Diphtheria) Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 1 March 2020. Archived from the original on 28 December 2019. Retrieved 27 July 2020.
"Tetanus and Diphtheria (Td) Vaccine". HealthLink BC. 13 June 2016. Archived from the original on 19 September 2020. Retrieved 18 April 2020.
"Diphtheria Vaccination". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 14 April 2020. Retrieved 18 April 2020.
"UpToDate". uptodate.com. Archived from the original on 15 September 2022. Retrieved 15 September 2022.
Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. (2008). Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) (PDF) (10th ed. (2nd printing) ed.). Washington, D.C.: Public Health Foundation. Archived from the original (PDF) on 24 September 2008. Retrieved 29 November 2008.
"Pediarix". U.S. Food and Drug Administration (FDA). 6 November 2019. Archived from the original on 22 September 2019. Retrieved 30 April 2022.
"Hexavalent 6-in-1 vaccine to be made available to newborn babies". GOV.UK. Archived from the original on 30 April 2022. Retrieved 30 April 2022.
Hamborsky J, Kroger A, Wolfe S, eds. (2015). "Chapter 21: Tetanus". Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: U.S. Centers for Disease Control and Prevention (CDC). ISBN 978-0990449119. Archived from the original on 30 December 2016. Retrieved 28 January 2020.
Hamborsky J, Kroger A, Wolfe S, eds. (2015). "Chapter 16: Pertussis". Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: U.S. Centers for Disease Control and Prevention (CDC). ISBN 978-0990449119. Archived from the original on 30 December 2016. Retrieved 28 January 2020.
"UpToDate". uptodate.com. Archived from the original on 28 August 2021. Retrieved 3 August 2020.
"Diphtheria-Tetanus-Pertussis Vaccine Information Statement | CDC". U.S. Centers for Disease Control and Prevention (CDC). 27 June 2022. Archived from the original on 28 December 2019. Retrieved 12 September 2022.
"Dutch National Immunization Program". National Institute for Public Health and the Environment. Archived from the original on 13 May 2020. Retrieved 18 April 2020.
"3-in-1 teenage booster overview". nhs.uk. 31 July 2019. Archived from the original on 19 April 2021. Retrieved 22 September 2020.
"Tetanus". 18 October 2017. Archived from the original on 23 July 2021. Retrieved 22 September 2020.
"Travel vaccinations". 23 October 2017. Archived from the original on 11 August 2021. Retrieved 22 September 2020.
"Summary of Pertussis Vaccination Recommendations | CDC". U.S. Centers for Disease Control and Prevention (CDC). 6 May 2022. Archived from the original on 12 September 2022. Retrieved 12 September 2022.
"Pertussis | Pregnancy and Whooping Cough | Your Baby Needs Vaccines on Time | CDC". U.S. Centers for Disease Control and Prevention (CDC). 14 February 2019. Archived from the original on 15 July 2020. Retrieved 30 July 2020.
"Tetanus, diphtheria, and pertussis vaccination". U.S. Centers for Disease Control and Prevention (CDC). 3 February 2020. Archived from the original on 21 July 2020. Retrieved 29 July 2020.
"Tdap (Pertussis) Vaccine and Pregnancy". U.S. Centers for Disease Control and Prevention (CDC). 10 April 2019. Archived from the original on 28 July 2020. Retrieved 28 July 2020.
"FDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Age". U.S. Food and Drug Administration (FDA) (Press release). 7 October 2022. Archived from the original on 7 October 2022. Retrieved 7 October 2022. This article incorporates text from this source, which is in the public domain.
Health Care Guideline: Routine Prenatal Care. Fourteenth Edition. Archived 24 June 2012 at the Wayback Machine By the Institute for Clinical Systems Improvement. July 2010.
Centers for Disease Control Prevention (CDC) (October 2011). "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011" (PDF). MMWR. Morbidity and Mortality Weekly Report. 60 (41): 1424–1426. PMID 22012116. Archived (PDF) from the original on 14 April 2021. Retrieved 30 July 2020. This article incorporates text from this source, which is in the public domain.
"Tdap (Pertussis) Vaccine and Pregnancy | CDC". U.S. Centers for Disease Control and Prevention (CDC). 15 January 2021. Archived from the original on 28 July 2020. Retrieved 12 September 2022.
"Adacel". The Australian Immunisation Handbook. 4 June 2018. Archived from the original on 18 June 2020. Retrieved 18 July 2020.
"Adacel (Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed))". Therapeutic Goods Administration (TGA). 18 July 2020. Archived from the original on 13 March 2020. Retrieved 18 July 2020.
"Triple Antigen IPV". St. Agnes Surgery. Archived from the original on 2 May 2021. Retrieved 2 May 2021.
"Adacel Polio". The Australian Immunisation Handbook. 5 June 2018. Archived from the original on 18 June 2020. Retrieved 18 July 2020.
"Adacel Polio (Pertussis Vaccine — Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated Poliovirus Type 1, 2 and 3 (Vero cell))". Therapeutic Goods Administration (TGA). 18 July 2020. Archived from the original on 13 March 2020. Retrieved 18 July 2020.
NHS https://www.nhs.uk/conditions/vaccinations/3-in-1-teenage-booster/ Archived 19 April 2021 at the Wayback Machine
"About Diphtheria, Tetanus, and Pertussis Vaccination". Centers for Disease Control and Prevention (CDC). 22 January 2020. Archived from the original on 7 January 2021. Retrieved 16 July 2020.
"Licensed Biological Products with Supporting Documents". U.S. Food and Drug Administration (FDA). 7 July 2020. Archived from the original on 21 September 2020. Retrieved 17 July 2020.
"Daptacel (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen- formaldehyde inactivated, bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen injection, suspension)". DailyMed. Sanofi Pasteur Inc. 14 May 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Infanrix- diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 19 July 2020. Retrieved 17 July 2020.
"Kinrix- diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine injection, suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 19 July 2020. Retrieved 17 July 2020.
"Pediarix (diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b- recombinant and inactivated poliovirus vaccine combined injection, suspension". DailyMed. GlaxoSmithKline Biologicals SA. 6 November 2019. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus b conjugate- tetanus toxoid conjugate vaccine kit)". DailyMed. Sanofi Pasteur Inc. 5 June 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Quadracel- diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine injection, suspension". DailyMed. Sanofi Pasteur Inc. 20 April 2020. Archived from the original on 18 July 2020. Retrieved 17 July 2020.
"Adacel Tdap (clostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen- formaldehyde inactivated, bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen injection, suspension)". DailyMed. 26 March 2020. Archived from the original on 18 July 2020. Retrieved 29 July 2020.
"Boostrix- tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed suspension". DailyMed. 25 April 2019. Archived from the original on 20 July 2020. Retrieved 29 July 2020.

who.int

immunizationdata.who.int

"Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage". World Health Organization (WHO).

worldcat.org

Carpenter CS, Lawler EC (2019). "Direct and Spillover Effects of Middle School Vaccination Requirements". American Economic Journal: Economic Policy. 11 (1): 95–125. doi:10.1257/pol.20170067. ISSN 1945-7731.